SHIRE ACQUISITIONS INVESTMENTS IRELAND
Shire Acquisitions Investments Ireland Designated Activity Company operates as a special purpose entity. The Company was formed for the purpose of issuing debt securities to repay existing credit facilities, refinance indebtedness, and for acquisition purposes.
SHIRE ACQUISITIONS INVESTMENTS IRELAND
Industry:
Biotechnology Health Care
Founded:
2015-12-21
Address:
Dublin, Dublin, Ireland
Country:
Ireland
Status:
Active
Contact:
353-1-429-7700
Similar Organizations
Biogenosis
Biogenosis is a biotechnology company.
probior
probior is distributes products for biotechnology, medicine and pharmacy.
More informations about "Shire Acquisitions Investments Ireland"
SHIRE ACQUISITIONS INVESTMENTS IRELAND DESIGNATED …
Find company research, competitor information, contact details & financial data for SHIRE ACQUISITIONS INVESTMENTS IRELAND DESIGNATED ACTIVITY COMPANY of DUBLIN. …See details»
Shire Acquisitions Investments Ireland - Crunchbase
Shire Acquisitions Investments Ireland Designated Activity Company operates as a special purpose entity. The Company was formed for the purpose of issuing debt securities to repay …See details»
Shire Acquisitions Investments Ireland DAC - Bloomberg.com
Shire Acquisitions Investments Ireland Designated Activity Company operates as a special purpose entity. The Company was formed for the purpose of issuing debt securities to repay …See details»
Shire Acquisitions Investments Ireland DAC - Irish Company Info
Shire Acquisitions Investments Ireland Designated Activity Company was set up on Monday the 21st of December 2015. Their current partial address is Dublin 2, and the company status is …See details»
Shire Acquisitions Investments Ireland Designated Activity Company
Shire Acquisitions Investments Ireland Designated Activity Company Company number 574225 Company type Other Incorporation date 21 Dec 2015. Latest confirmation statement 31 Dec …See details»
Shire Acquisitions Investments Ireland DAC - Drug pipelines, …
Explore Shire Acquisitions Investments Ireland DAC with its drug pipeline, therapeutic area, technology platform, . Biomedical products. Data. Feature. Plans. Sign Up for Free. Request …See details»
Shire 2025 Company Profile: Valuation, Investors, Acquisition
Shire Investments & Acquisitions (52) Shire’s most recent deal was a Merger/Acquisition with Sanaplasma. The deal was made on 06-Sep-2018. Company Name Deal Date Deal Type ...See details»
SHIRE ACQUISITIONS INVESTMENTS IRELAND DESIGNATED …
Dec 31, 2022 Free and open company data on Ireland company SHIRE ACQUISITIONS INVESTMENTS IRELAND DESIGNATED ACTIVITY COMPANY (company number 574225), …See details»
SHIRE ACQUISITIONS INVESTMENTS IRELAND DESIGNATED …
Jun 27, 2024 Takeda Pharmaceutical Company Limited (Takeda), Shire Acquisitions Investments Ireland DAC, an Irish designated activity company and wholly-owned indirect …See details»
SHIREACQUISITIONS INVESTMENTS IRELAND DAC 2.400
SHIRE ACQUISITIONS INVESTMENTS IRELAND DAC . 2.400% Senior Notes due 2021 . Up to $3,300,000,000 . CUSIP: 82481L AB5 ISIN: US82481LAB53 . No. _____ $_____ SHIRE …See details»
Shire Acquisitions Investments Ireland Designated Activity …
Find up to date company insights for 'Shire Acquisitions Investments Ireland Designated Activity Company'. Get Contact details, financial insights, industry benchmarks, competitors from …See details»
Shire Acquisitions Investments Ireland Designated Activity …
Find up to date company insights for Shire Acquisitions Investments Ireland Designated Activity Company. Get Contact details, financial insights, industry benchmarks, competitors from …See details»
Shire Acquisitions Investments Ireland DAC 3,2% 16/26 - Börse …
Shire Acquisitions Investments Ireland DAC 3,2% 16/26 price in real-time (A186SQ / US82481LAD10) charts and analyses, news, key data, turnovers, company data.See details»
Shire’s $12.1 Billion Registered Senior Debt Offering
Sep 23, 2016 Cravath represented the underwriters, led by Barclays, Bank of America Merrill Lynch and Morgan Stanley, in connection with the US$12.1 billion registered senior debt …See details»
Shire Acquisitions Investments Ireland - Crunchbase
Shire Acquisitions Investments Ireland is a biotechnology company. Search Crunchbase. Start Free TrialSee details»
Slaughter and May advised Shire plc on $12.1 billion debt offering
Slaughter and May advised Shire plc on the English law aspects of the successful $12.1 billion SEC-registered debt offering by its wholly owned subsidiary, Shire Acquisitions Investments …See details»
SHIRE ACQUISITIONS INVESTMENTS IRELAND DESIGNATED …
SHIRE ACQUISITIONS INVESTMENTS IRELAND DESIGNATED ACTIVITY COMPANY is an active company registered in Ireland. It is identified by the legal entity identifier (LEI) …See details»
Davis Polk Advises Shire on Its $2.325 Billion Concurrent Tender …
Davis Polk advised Shire plc on concurrent tender offers by Baxalta Incorporated and Shire Acquisitions Investments Ireland DAC (“SAIIDAC”), both wholly owned subsidiaries of Shire, …See details»
Takeda divesting former-Shire plant in Ireland - Bioprocess Insider
Feb 3, 2020 Takeda has identified a biomanufacturing facility in Ireland as no longer required in a strategic review of its network following the acquisition of Shire. BioProcess International is …See details»
Shire Acquisitions Investments Ireland Designated Activity Company
Shire Acquisitions Investments Ireland Designated Activity Company was set up on Monday the 21st of December 2015. Their current partial address is Dublin 2, and the company status is …See details»